Total antioxidant blood capacity in patients with type 2 diabetes mellitus and distal symmetrical polyneuropathy;Totalni antioksidativni kapacitet plazme kod bolesnika sa dijabetesom melitusom tip 2 i distalnom simetričnom polineuropatijom

Vojnosanitetski Pregled

Volumn 65, Issue 9, 2008, Pages 663-669

  Dordević, Gordana ^a   Durić, Stojanka ^a   Apostolski, Slobodan ^b   Dordević, Vidosava ^c   Živković, Miroslava ^a  

^a Klinika za neurologiju   (Serbia)

^b Centar za Medicinsku Biohemiju   (Serbia)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Diabetes mellitus; Diabetic neuropathies; Oxidative stress

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ANTIOXIDANT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; POLYNEUROPATHY; AGED; BLOOD; DIABETIC NEUROPATHY; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; EVOKED POTENTIALS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; POLYNEUROPATHIES;

EID: 54049147832     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/vsp0809663d     Document Type: Article

References (32)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27 Suppl 1: S5-S10. (Pubitemid 38197462)
2. Feldman EL. Oxidative stress and diabetic neuropathy: a new understanding of an old problem. J Clin Invest 2003; 111(4): 431-433 (Pubitemid 36227996)
3. Kuroki T, Isshiki K, King GL. Oxidative stress: the lead or supporting actor in the pathogenesis of diabetic complications. J Am Soc Nephrol 2003; 14(8 Suppl 3): S216-20. (Pubitemid 36903928)
4. Ziegler D, Hanefeld M, Ruhnau KJ, Meissner HP, Lobisch M, Schütte K, et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 1995; 38(12): 1425-1433
5. Reljanović M, Reichel G, Rett K, Lobisch M, Schuette K, Möller W, et al. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy. Free Radic Res 1999; 31(3): 171-179 (Pubitemid 29435878)
6. Ziegler D, Hanefeld M, Ruhnau KJ, Hasche H, Lobisch M, Schütte K, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care 1999; 22(8): 1296-1301 (Pubitemid 29350240)
7. Ametov AS, Barinov A, Dyck PJ, Hermann R, Kozlova N, Litchy WJ, et al. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care 2003; 26(3): 770-776 (Pubitemid 36929342)
8. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997; 46 Suppl 2: S62-6. (Pubitemid 27377401)
9. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997; 20(3): 369-373
10. Bonnefont-Rousselot D, Bastard JP, Jaudon MC, Delattre J. Consequences of the diabetic status on the oxidant/antioxidant balance. Diabetes Metab 2000; 26(3): 163-176 (Pubitemid 30435761)
11. Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15(2): 212-216
12. Koraćević D, Koraćević G, Crossed D signorCrossed d signević V, Andrejević S, Ćosić V. Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 2001; 54(5): 356-361
13. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005; 4(1): 5. (Pubitemid 41460764)
14. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: a review. J Biochem Mol Toxicol 2003; 17(1): 24-38. (Pubitemid 36410972)
15. Crossed D signorCrossed d signević VB, Pavlović DD, Kocić GM, editors. Biochemistry of free radicaly. Niš: Medicinski fakultet 2000. (Serbian)
16. Gallou G, Ruelland A, Legras B, Maugendre D, Allannic H, Cloarec L. Plasma malondialdehyde in type 1 and type 2 diabetic patients. Clin Chim Acta 1993; 214(2): 227-234 (Pubitemid 23102293)
17. Gugliucci A, Menini T, Stahl AJ. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol Int 1994; 32(1): 139-147 (Pubitemid 24077252)
18. Nourooz-ZJ, Rahimi A, Sarmadi TJ, Tritschler H, Rosen P, Halliwell B, et al. Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997; 40(6): 647-653 (Pubitemid 27288109)
19. Prashant AV, D'souza HV, D'souza B. Age related changes in lipid peroxidation and antioxidants in elderly people. Indian Jour Clin Bioch 2007; 22(1): 131-134 ?
20. Ramakrishna V, Jailkhani R. Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2007; 2: 22.
21. Horoz M, Bolukbas C, Bolukbas FF, Sabuncu T, Aslan M, Sarifakiogullari S, et al. Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis. BMC Gastroenterol 2005; 5: 35. (Pubitemid 41684581)
22. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43(8): 1010-1014 (Pubitemid 24230705)
23. Ceriello A, Bortolotti N, Pirisi M, Crescentini A, Tonutti L, Motz E, et al. Total plasma antioxidant capacity predicts thrombosis-prone status in NIDDM patients. Diabetes Care 1997; 20(10): 1589-1593 (Pubitemid 27415039)
24. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, et al. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27(6): 484-490 (Pubitemid 27288358)
25. Opara EC, Abdel-Rahman E, Soliman S, Kamel WA, Souka S, Lowe JE, et al. Depletion of total antioxidant capacity in type 2 diabetes. Metabolism 1999; 48(11): 1414-1417 (Pubitemid 29536441)
26. Valabhji J, McColl AJ, Richmond W, Schachter M, Rubens MB, Elkeles RS. Total antioxidant status and coronary artery calcification in type 1 diabetes. Diabetes Care 2001; 24(9): 1608-1613 (Pubitemid 33716457)
27. Pinzani P, Petruzzi E, Orlando C, Gallai R, Serio M, Pazzagli M. Serum antioxidant capacity in healthy and diabetic subjects as determined by enhanced chemiluminescence. J Biolumin Chemilumin 1998; 13(5): 321-325 (Pubitemid 128447871)
28. Faure P, Wiernsperger N, Polge C, Favier A, Halimi S. Impairment of the antioxidant properties of serum albumin in patients with diabetes: protective effects of metformin. Clin Sci (Lond) 2008; 114(3): 251-256 (Pubitemid 351294000)
29. Del Razo LM, Gonzalez JC, De La Pena JE, Salazar FS, Vargas GG. Total antioxidant capacity in Type 2 diabetic people living in arsenic-endemic area in North Mexico. Epidemiology 2007; 18(5): p. S134.
30. Rahbani-Nobar ME, Rahimi-Pour A, Rahbani-Nobar M, Adi-BEig F, Mirhashemi SM. Total antioxidant capacity, superoxide dismutase and glutathion peroxidase in diabetic patients. Med Jour Islamic Academy Sci 1999; 12(4): 109-114
31. Sasari M, Nyakas C. Time dependent changes in oxidative metabolism during chronic diabetes in rats. Acta Biologica Szegediensis 2003; 47: 153-158 (Pubitemid 38262737)
32. Majithiya JB, Balaraman R. Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 2005; 46(5): 697-705. (Pubitemid 41527764)